Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Early daratumumab treatment improves renal outcomes in newly diagnosed myeloma patients admitted with kidney injury; out of 9 who required dialysis, 4/7 (57.1%) and 6/7 (85.7%) were dialysis independent at 3 and 12 months, respectively.”
Authors: Bridget Kim, Jack Malespini, Matthew Lei, Samuel Han, Cole Minsky, Andrew Branagan, Elizabeth O’Donnell, Diana Cirstea, Noopur Raje, Andrew Yee.
More posts featuring Robert Orlowski.
